 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning Genomics One Corporation
|
-
Genomics One Corporation announces the acquisition of the assets of Abionix Sarl
(12 Dec 2005)
Genomics One Corporation announced that it has acquired the assets of Abionix Sarl, which complement Genomics One's BioDefence intellectual property portfolio and its sales and marketing capabilities. Genomics One had signed a co-distribution and ...
-
Genomics One Corporation completes the sale of the BioCan Scientific Inc's assets to Medicorp Inc.
(08 Jun 2005)
Genomics One Corporation announced it has completed an Asset Purchase Transaction that was previously announced on May 27th, with Medicorp Inc. for an estimated value of $904,063. On May 31st, 2005, Medicorp Inc., acquired substantially all of the ...
-
Genomics One Corporation announces the sale of its BioCan Scientific Inc. subsidiaries to Medicorp Inc.
(31 May 2005)
Genomics One Corporation announced that its Board of Directors has approved the terms of a Sale Transaction between Genomics One and Medicorp Inc. of Montreal for the sale of the assets of its BioCan Scientific subsidiaries in Canada and in the US. ...
-
MGPi and Explorer Global have filed a motion against Genomics One
(13 Apr 2005)
Genomics One Corporation announced that MGPi and Explorer Global Inc. have filed a motion against Genomics One, its President & CEO, Dr. Suzanne L. Lebel and 2 former employees of Dephy Technologies Inc. ("Dephy"), a company that Genomics One has ...
-
Genomics One signs agreement with french company ABIONIX
(05 Apr 2005)
Genomics One Corporation announced that it had signed a co-development and co-distribution agreement in the field of Mass Spectrometry with ABIONIX S.a.r.l., a Company based in France. The Corporation also announced that it has entered into a ...
|
|
|
|
|
Top
